MedTrace Logo

Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams

NCT02396420 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2018-11-06

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate improvement in symptoms related to benign prostatic hyperplasia (BPH) in men treated with prostate artery embolization (PAE) using Embosphere Microspheres.

Conditions

  • Prostatic Hyperplasia

Interventions

DEVICE

Embosphere Microspheres

Sponsors & Collaborators

  • South Florida Medical Imaging, PA

    lead OTHER

Principal Investigators

  • Michael Rush, MD · South Florida Medical Imaging, Holy Cross Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
89 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-24
Primary Completion
2016-11-17
Completion
2016-11-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02396420 on ClinicalTrials.gov